Orris

Citicholin

Reading File
Searching the Web

citicoline CDP-choline mechanism uses clinical evidence 2025

Finding Sources
Searching PubMed

citicoline neuroprotection cognitive function

Reading File
Reading File
Searching PubMed

citicoline stroke dementia

Here is a thorough overview of Citicoline (CDP-choline / Cytidine 5'-diphosphocholine):

Citicoline (CDP-Choline)

What It Is

Citicoline is an endogenous nucleotide that serves as a key intermediate in the biosynthesis of phosphatidylcholine (PC), the most abundant phospholipid in neuronal cell membranes. It is both produced naturally in the body and available as a dietary supplement / medical food. Upon ingestion, it is rapidly hydrolyzed into cytidine (which converts to uridine in the brain) and choline, both of which cross the blood-brain barrier.

Mechanism of Action

Citicoline works through several complementary pathways:
  1. Membrane phospholipid synthesis - Serves as the activated choline donor (CDP-choline) in the Kennedy cycle, driving synthesis of phosphatidylcholine in neuronal membranes. This supports membrane integrity and repair after injury.
  2. Neurotransmitter support - Increases CNS levels of noradrenaline and dopamine, and serves as a choline donor for acetylcholine synthesis. This makes it relevant in cholinergic conditions like Alzheimer's disease.
  3. Mitochondrial energy production - Boosts mitochondrial function and ATP generation, which is important for neurons under ischemic or hypoxic stress.
  4. Neuroprotection - Has general neuroprotective effects following hypoxic or ischemic brain injury, thought to involve reducing free fatty acid accumulation, glutamate excitotoxicity, and oxidative damage.

Clinical Uses

IndicationEvidence / Notes
Ischemic stroke / cerebrovascular diseaseTwo systematic reviews found consistent positive effects on stroke recovery rate and reduced cognitive impairment severity in older adults with cerebrovascular disease
Alzheimer's diseasePreliminary data suggest 1,000 mg/day may improve cognitive performance in early stages; listed as a "medical food" for this indication
Traumatic brain injury (TBI)Meta-analysis of clinical trials shows benefit; widely used in neuro-ICU settings in many countries
GlaucomaTwo-year clinical trials suggest benefit on optic nerve function in open-angle glaucoma at 500 mg/day with periodic dosing
Cognitive agingSmall but consistent improvements in age-related cognitive decline
Vascular dementiaMitigates severity of cognitive impairment related to cerebrovascular disease
Note (2025): A 2025 systematic review and meta-analysis comparing citicoline vs. choline alphoscerate in dementia found that choline alphoscerate was more effective than citicoline across cognitive function, interpersonal relationships, and somatic functioning as measured by SCAG scores, though dropout rates were similar. (Frontiers in Neurology, 2025)

Dosage

  • Alzheimer's / cognitive decline: 300-1,000 mg/day orally
  • Stroke recovery: Typically 500-2,000 mg/day (oral or IV)
  • Glaucoma: 500 mg/day with cycling schedule (4 months on / 2 months off)

Safety Profile

Citicoline is considered one of the safest forms of supplemental choline - it is several-fold less toxic than choline itself in toxicology studies. It is generally very well tolerated with minimal adverse effects.

Biochemistry Context

In the Kennedy cycle (de novo phosphatidylcholine synthesis):
  • Choline → phosphocholine (choline kinase + ATP)
  • Phosphocholine + CTP → CDP-choline + PPi (rate-limiting step, CTP:phosphocholine cytidylyltransferase)
  • CDP-choline + DAG → phosphatidylcholine + CMP
This is the same pathway that produces surfactant (DPPC) in the lungs, which is relevant in neonatal lung development as well.
Sources:
This is a shared conversation. Sign in to Orris to start your own chat.